Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World: The Driving Engine Behind Diabetic Retinopathy Market Evolution in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Diabetic Retinopathy Market Size Growth Forecast: What to Expect by 2025?
The diabetic retinopathy market has experienced robust expansion over the last few years, with projections indicating a rise from $8.61 billion in 2024 next year to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%; this historical upward trend is largely owing to several factors, including an expanding elderly demographic, the mounting incidence of diabetes, greater knowledge concerning diabetic retinopathy, enhancements in medical infrastructure, in addition to escalating outlays on healthcare.

How Will the Diabetic Retinopathy Market Size Evolve and Grow by 2029?
Anticipation points toward substantial expansion in the diabetic retinopathy market over the coming years, projected to reach a valuation of $12.5 billion by 2029, sustained by a compound annual growth rate (CAGR) of 7.8%. This upward trajectory during the forecast timeframe is fueled by several key factors: the uptake of tailored medical strategies, the broader reach of telehealth options, innovation in new treatment modalities, the utilization of diagnostics at the patient's location, and the implementation of remote physiological oversight. Significant currents shaping this period involve integrating highly specific medical approaches into diabetic retinopathy care, a greater emphasis placed on identifying the condition early and taking preventative action, the rising utilization of remote eye care services, escalated investigation into genetic therapies, and ongoing progress within technology used for capturing retinal images.

View the full report here:
https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report

What Drivers Are Propelling the Growth of Diabetic Retinopathy Market Forward?
Increased incidence of diabetes is anticipated to be a key factor fueling the expansion of the diabetic retinopathy market moving ahead. Diabetes, characterized as a chronic metabolic condition resulting in elevated blood sugar, sees its growing frequency attributed primarily to factors like excess weight, obesity, inherited predispositions, and sedentary lifestyles; in individuals affected by diabetes, this excessive glucose concentration has the potential to harm the retina, which is fundamentally the light-sensitive tissue at the back of the eye responsible for transmitting visual information to the brain via the optic nerve. To illustrate this trend's significance, data released in March 2024 from the UK's Office for Health Improvement and Disparities indicated a 22% improvement in the number of people with type 1 diabetes receiving all eight advised care components between March 2022 and March 2023, with type 2 diabetes seeing a 21% corresponding uplift; furthermore, the National Diabetes Audit documented a record high of 37.9% of the population achieving their target HbA1c levels, establishing a clear connection between the escalating rate of diabetes and the subsequent demand within the diabetic retinopathy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12187&type=smp

Which Emerging Trends Are Transforming the Diabetic Retinopathy Market in 2025?
The diabetic retinopathy sector is witnessing a significant surge driven by innovations in technology. Leading firms within the high-volume parenteral sector are integrating novel technological solutions to fortify their competitive standing. A prime illustration of this trend is the introduction of the Welch Allyn RetinaVue 100 Imager PRO into the South Korean market by US healthcare provider Baxter International Inc. in July 2022. Such technological deployments aim to enable the identification of diabetic retinopathy within general practitioner environments, as the RetinaVue system effectively boosts adherence to critical annual diabetic retinal exams (DREs) by offering rapid and convenient screening directly within standard primary care appointments.

What Are the Key Segments in the Diabetic Retinopathy Market?
The diabetic retinopathymarket covered in this report is segmented -

1) By Type: Proliferative Diabetic Retinopathy; Non-Proliferative Diabetic Retinopathy
2) By Treatment: Anti-VEGF Drugs; Intraocular Steroid Injection; Laser Photocoagulation; Vitreoretinal Surgery
3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users

Subsegments:
1) By Proliferative Diabetic Retinopathy (PDR): Neovascularization; Vitreous Hemorrhage; Tractional Retinal Detachment
2) By Non-Proliferative Diabetic Retinopathy (NPDR): Mild NPDR; Moderate NPDR; Severe NPDR

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12187&type=smp

Who Are the Key Players Shaping the Diabetic Retinopathy Market's Competitive Landscape?
Major companies operating in the diabetic retinopathy market include Pfizer Inc., F-Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG, Novartis AG, Ellex Medical Lasers Ltd., Abbott Laboratories Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Icon Bioscience Inc., Allergan plc., Genentech Inc., Aurobindo Pharma, Santen Pharmaceutical Co. Ltd., Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co. Ltd., IRIDEX Corporation, Alimera Science Inc., Kowa Company Ltd., Ocular Therapeutix Inc., Aerpio Pharmaceuticals Inc., Kodiak Sciences Inc., Oxurion NV, Graybug Vision Inc., Ampio Pharmaceuticals Inc.

What Geographic Markets Are Powering Growth in the Diabetic Retinopathy Market?
North America was the largest region in the diabetic retinopathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12187

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.